Status:
ACTIVE_NOT_RECRUITING
Transcutaneous CO2 Monitoring at Home for Children With Neuromuscular Disease
Lead Sponsor:
The Hospital for Sick Children
Conditions:
Sleep Disorder; Breathing-Related
Central Apnea
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
There is an unmet demand for the evaluation of nocturnal hypoventilation in children with NMD. An ambulatory screening tool that can reliably facilitate timely diagnosis and treatment in these childre...
Eligibility Criteria
Inclusion
- children with a confirmed diagnosis of NMD that meet criteria for evaluating SDB as per international recommendations
- lives within the greater Toronto area.
Exclusion
- known diagnosis of nocturnal hypoventilation
- current ventilatory support
- physician diagnosis of active upper respiratory tract infection (fever, increased cough, rhinorrhea, increased nasal congestion, sore throat, headache, malaise and/or sneezing).
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03478566
Start Date
October 1 2018
End Date
September 1 2023
Last Update
April 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G 1X8